日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The multilayered transcriptional architecture of glioblastoma ecosystems.

胶质母细胞瘤生态系统的多层转录结构

Nomura Masashi, Spitzer Avishay, Johnson Kevin C, Garofano Luciano, Nehar-Belaid Djamel, Galili Darnell Noam, Greenwald Alissa C, Bussema Lillian, Oh Young Taek, Varn Frederick S, D'Angelo Fulvio, Gritsch Simon, Anderson Kevin J, Migliozzi Simona, Gonzalez Castro L Nicolas, ChowdhFury Tamrin, Robine Nicolas, Reeves Catherine, Park Jong Bae, Lipsa Anuja, Hertel Frank, Golebiewska Anna, Niclou Simone P, Nusrat Labeeba, Kellet Sorcha, Das Sunit, Moon Hyo Eun, Paek Sun Ha, Bielle Franck, Laurenge Alice, Di Stefano Anna Luisa, Mathon Bertrand, Picca Alberto, Sanson Marc, Tanaka Shota, Saito Nobuhito, Ashley David M, Keir Stephen T, Ligon Keith L, Huse Jason T, Yung W K Alfred, Lasorella Anna, Verhaak Roel G W, Iavarone Antonio, Suvà Mario L, Tirosh Itay

Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1

EANO成人胶质瘤、神经胶质瘤和神经元肿瘤靶向治疗选择合理分子检测指南更新版-更新1

van den Bent, Martin J; Franceschi, Enrico; Touat, Mehdi; French, Pim J; Idbaih, Ahmed; Lombardi, Giuseppe; Rudà, Roberta; Schweizer, Leonille; Capper, David; Sanson, Marc; Wesseling, Pieter; Weller, Michael; Eoli, Marica; Anghileri, Elena; Bielle, Franck; Euskirchen, Phillipp; Geurts, Marjolein; Wen, Patrick Y; Preusser, Matthias

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

成人胶质母细胞瘤:神经肿瘤学会 (SNO) 和欧洲神经肿瘤学会 (EANO) 关于当前治疗和未来方向的共识性综述

Wen, Patrick Y; Weller, Michael; Lee, Eudocia Q; Touat, Mehdi; Khasraw, Mustafa; Rahman, Rifaquat; Platten, Michael; Lim, Michael; Winkler, Frank; Horbinski, Craig; Verhaak, Roel G W; Huang, Raymond Y; Ahluwalia, Manmeet S; Albert, Nathalie L; Tonn, Joerg-Christian; Schiff, David; Barnholtz-Sloan, Jill S; Ostrom, Quinn; Aldape, Kenneth D; Batchelor, Tracy T; Bindra, Ranjit S; Chiocca, E Antonio; Cloughesy, Timothy F; DeGroot, John F; French, Pim; Galanis, Evanthia; Galldiks, Norbert; Gilbert, Mark R; Hegi, Monika E; Lassman, Andrew B; Le Rhun, Emilie; Mehta, Minesh P; Mellinghoff, Ingo K; Minniti, Giuseppe; Roth, Patrick; Sanson, Marc; Taphoorn Andreas, Martin J B; Weiss, von Deimling Tobias; Wick, Wolfgang; Zadeh, Gelareh; Reardon, David A; Chang, Susan M; Short, Susan C; van den Bent, Martin J; Preusser, Matthias

Functional analysis of telomere maintenance mechanisms is more informative than immunohistochemistry for ATRX mutation interpretation in Gliomas

对于胶质瘤中ATRX突变的解读,端粒维持机制的功能分析比免疫组织化学更具信息价值。

Guerriau, Clemence; Léonce, Camille; Carpentier, Catherine; Mokhtari, Karima; Bielle, Franck; Dridi-Aloulou, Amel; Lomonte, Patrick; Meyronet, David; Sanson, Marc; Castro-Vega, Luis; Poncet, Delphine Aude

Advances in the management of patients with IDH-mutant glioma

IDH突变型胶质瘤患者治疗进展

Rossi, Jessica; Picca, Alberto; Santonocito, Orazio Santo; Schembari, Silvia; Testaverde, Lorenzo; Sanson, Marc; Berzero, Giulia; Di Stefano, Anna Luisa

Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with IDH-Mutant Glioma

将编辑后的磁共振波谱技术应用于临床实践或可改善IDH突变型胶质瘤患者的治疗

Nichelli, Lucia; Cadin, Capucine; Lazzari, Patrizia; Mathon, Bertrand; Touat, Mehdi; Sanson, Marc; Bielle, Franck; Marjańska, Małgorzata; Lehéricy, Stéphane; Branzoli, Francesca

A Specific Methylation Class Identifies BAP1-Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid Histology

特定的甲基化类型可识别BAP1缺陷型脑膜瘤,包括分化不良的非横纹肌样组织学类型的脑膜肿瘤

Drabent, Philippe; Touat, Mehdi; Benusiglio, Patrick R; Euskirchen, Philipp; Coulet, Florence; Oumoussa, Badreddine Mohand; de la Fouchardière, Arnaud; de Montpreville, Vincent Thomas; Jacob, Julian; Bernardeschi, Daniele; Laurent-Puig, Pierre; Sanson, Marc; Kalamarides, Michel; Bielle, Franck

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.

突变型 IDH 抑制剂可诱导 IDH 突变型少突胶质细胞瘤的谱系分化

Spitzer Avishay, Gritsch Simon, Nomura Masashi, Jucht Alexander, Fortin Jerome, Raviram Ramya, Weisman Hannah R, Gonzalez Castro L Nicolas, Druck Nicholas, Chanoch-Myers Rony, Lee John J Y, Mylvaganam Ravindra, Lee Servis Rachel, Fung Jeremy Man, Lee Christine K, Nagashima Hiroaki, Miller Julie J, Arrillaga-Romany Isabel, Louis David N, Wakimoto Hiroaki, Pisano Will, Wen Patrick Y, Mak Tak W, Sanson Marc, Touat Mehdi, Landau Dan A, Ligon Keith L, Cahill Daniel P, Suvà Mario L, Tirosh Itay

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments

在免疫抑制环境下发生的非霍奇金淋巴瘤,其免疫基因组学特征受Epstein-Barr病毒和免疫状态的影响。

Baron, Marine; Labreche, Karim; Veyri, Marianne; Désiré, Nathalie; Bouzidi, Amira; Seck-Thiam, Fatou; Charlotte, Frédéric; Rousseau, Alice; Morin, Véronique; Nakid-Cordero, Cécilia; Abbar, Baptiste; Picca, Alberto; Le Cann, Marie; Balegroune, Noureddine; Gauthier, Nicolas; Theodorou, Ioannis; Touat, Mehdi; Morel, Véronique; Bielle, Franck; Samri, Assia; Alentorn, Agusti; Sanson, Marc; Roos-Weil, Damien; Haioun, Corinne; Poullot, Elsa; De Septenville, Anne Langlois; Davi, Frédéric; Guihot, Amélie; Boelle, Pierre-Yves; Leblond, Véronique; Coulet, Florence; Spano, Jean-Philippe; Choquet, Sylvain; Autran, Brigitte

TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma

TARGET:一项 I/II 期开放标签多中心研究,旨在评估 fexagratinib 在复发/难治性 FGFR 融合阳性胶质瘤患者中的安全性和有效性。

Picca, Alberto; Di Stefano, Anna Luisa; Savatovsky, Julien; Ducray, François; Chinot, Olivier; Moyal, Elisabeth Cohen-Jonathan; Augereau, Paule; Le Rhun, Emilie; Schmitt, Yohann; Rousseaux, Nabila; Yepnang, Ariane Murielle Mbekwe; Estellat, Candice; Charbonneau, Frédérique; Letourneur, Quentin; Branger, Dominique Figarella; Meyronet, David; Fardeau, Christine; Mokhtari, Karima; Bielle, Franck; Iavarone, Antonio; Sanson, Marc